Fig. 8

Predicted interactions of identified differentially expressed proteins. Protein abbreviations and corresponding full name are shown: LOC558408 (troponin I); rab2a (RAB2A, member RAS oncogene family); myhb (myosin, heavy chain b); mapk12a (mitogen-activated protein kinase 12a); cat (catalase); fth1a (ferritin, heavy polypeptide 1a); atp5a1 (ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle); prkcbb (protein kinase C, beta b); PARP4 [poly (ADP-ribose) polymerase family, member 4]; tp53 (tumor protein p53); arih1l (ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 like); rpl26 (ribosomal protein L26); tpi1b (triosephosphate isomerase 1b); MDH2 [malate dehydrogenase 2, NAD (mitochondrial)]; ND1(NADH dehydrogenase 1, mitochondrial); COX1 (cytochrome c oxidase I, mitochondrial)); eif2ak2 (eukaryotic translation initiation factor 2-alpha kinase 2); celf2 (cugbp, Elav-like family member 2); eef1a1l1 (eukaryotic translation elongation factor 1 alpha 1, like 1); pfn2l (profilin 2 like); jarid2b (jumonji, AT rich interactive domain 2b); STX1A [syntaxin 1A (brain)]; rps9 (ribosomal protein S9); rpl10a (ribosomal protein L10a)